Cost-Effectiveness of Pharmacotherapy to Reduce Obesity

  title={Cost-Effectiveness of Pharmacotherapy to Reduce Obesity},
  author={Jacob Lennert Veerman and Jan J. Barendregt and Megan Forster and Theo Vos},
  booktitle={PloS one},
AIMS Obesity causes a high disease burden in Australia and across the world. We aimed to analyse the cost-effectiveness of weight reduction with pharmacotherapy in Australia, and to assess its potential to reduce the disease burden due to excess body weight. METHODS We constructed a multi-state life-table based Markov model in Excel in which body weight influences the incidence of stroke, ischemic heart disease, hypertensive heart disease, diabetes mellitus, osteoarthritis, post-menopausal… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS
5 Citations
49 References
Similar Papers


Publications citing this paper.


Publications referenced by this paper.
Showing 1-10 of 49 references

The Burden of Disease and Injury in Australia. Canberra: AIHW

  • S Begg, T Vos, B Barker, C Stevenson, L Stanley
  • 2007
Highly Influential
5 Excerpts

Body mass index and risk of diabetes mellitus in the Asia-Pacific region

  • C Ni Mhurchu, V Parag, M Nakamura, A Patel, A Rodgers
  • Asia Pac J Clin Nutr
  • 2006
Highly Influential
12 Excerpts

Overweight and obesity (high body mass index)

  • WP James, R Jackson-Leach, C Ni Mhurchu, E Kalamara, M Shayeghi
  • Comparative quantification of health risks…
  • 2004
Highly Influential
14 Excerpts

Similar Papers

Loading similar papers…